Literature DB >> 25739476

DEGRO/DGK guideline for radiotherapy in patients with cardiac implantable electronic devices.

Benjamin Gauter-Fleckenstein1, Carsten W Israel, Marc Dorenkamp, Jürgen Dunst, Mattias Roser, Rainer Schimpf, Volker Steil, Jörg Schäfer, Ulrike Höller, Frederik Wenz.   

Abstract

An increasing number of patients undergoing radiotherapy (RT) have cardiac implantable electronic devices [CIEDs, cardiac pacemakers (PMs) and implanted cardioverters/defibrillators (ICDs)]. Ionizing radiation can cause latent and permanent damage to CIEDs, which may result in loss of function in patients with asystole or ventricular fibrillation. Reviewing the current literature, the interdisciplinary German guideline (DEGRO/DGK) was developed reflecting patient risk according to type of CIED, cardiac condition, and estimated radiation dose to the CIED. Planning for RT should consider the CIED specifications as well as patient-related characteristics (pacing-dependent, previous ventricular tachycardia/fibrillation). Antitachyarrhythmia therapy should be suspended in patients with ICDs, who should be under electrocardiographic monitoring with an external defibrillator on stand-by. The beam energy should be limited to 6 (to 10) MV CIEDs should never be located in the beam, and the cumulative scatter radiation dose should be limited to 2 Gy. Personnel must be able to respond adequately in the case of a cardiac emergency and initiate basic life support, while an emergency team capable of advanced life support should be available within 5 min. CIEDs need to be interrogated 1, 3, and 6 months after the last RT due to the risk of latent damage.

Entities:  

Mesh:

Year:  2015        PMID: 25739476     DOI: 10.1007/s00066-015-0817-3

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN: 0179-7158            Impact factor:   3.621


  61 in total

1.  The cardiac pacemaker patient--might the pacer be directly irradiated?

Authors:  A Tsekos; F Momm; M Brunner; R Guttenberger
Journal:  Acta Oncol       Date:  2000       Impact factor: 4.089

2.  Influence of high-energy photon beam irradiation on pacemaker operation.

Authors:  J Mouton; R Haug; A Bridier; B Dodinot; F Eschwege
Journal:  Phys Med Biol       Date:  2002-08-21       Impact factor: 3.609

3.  X-ray radiation causes electromagnetic interference in implantable cardiac pacemakers.

Authors:  Minoru Hirose; Keiichi Tachikawa; Masanori Ozaki; Naoki Umezawa; Toshihiro Shinbo; Kenichi Kokubo; Hirosuke Kobayashi
Journal:  Pacing Clin Electrophysiol       Date:  2010-10       Impact factor: 1.976

4.  Effects of CT irradiation on implantable cardiac rhythm management devices.

Authors:  Cynthia H McCollough; Jie Zhang; Andrew N Primak; Wesley J Clement; John R Buysman
Journal:  Radiology       Date:  2007-04-26       Impact factor: 11.105

5.  Radiation therapy with implanted cardiac pacemaker devices: a clinical and dosimetric analysis of patients and proposed precautions.

Authors:  T Wadasadawala; A Pandey; J P Agarwal; R Jalali; S G Laskar; S Chowdhary; A Budrukkar; R Sarin; D Deshpande; A Munshi
Journal:  Clin Oncol (R Coll Radiol)       Date:  2010-10-30       Impact factor: 4.126

6.  Pacemakers in radiotherapy.

Authors:  F A Little
Journal:  Clin Oncol (R Coll Radiol)       Date:  1994       Impact factor: 4.126

7.  Interference detection in implantable defibrillators induced by therapeutic radiation therapy.

Authors:  G J Uiterwaal; B G F Springorum; E Scheepers; G S de Ruiter; C W Hurkmans
Journal:  Neth Heart J       Date:  2006-10       Impact factor: 2.380

8.  External cardioversion of atrial fibrillation in patients with implanted pacemaker or cardioverter-defibrillator systems: a randomized comparison of monophasic and biphasic shock energy application.

Authors:  Johannes C Manegold; Carsten W Israel; Joachim R Ehrlich; Gabor Duray; Dmitri Pajitnev; Florian T Wegener; Stefan H Hohnloser
Journal:  Eur Heart J       Date:  2007-06-14       Impact factor: 29.983

9.  Implanted cardiac defibrillator care in radiation oncology patient population.

Authors:  Daphna Y Gelblum; Howard Amols
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008-10-30       Impact factor: 7.038

10.  Successful radiation treatment of anaplastic thyroid carcinoma metastatic to the right cardiac atrium and ventricle in a pacemaker-dependent patient.

Authors:  Tina Dasgupta; Igor J Barani; Mack Roach
Journal:  Radiat Oncol       Date:  2011-02-14       Impact factor: 3.481

View more
  21 in total

1.  Management of patients with implanted cardiac devices during radiotherapy: results of a Spanish survey in radiation oncology departments.

Authors:  S Sabater; A Montero; T López Fernández; J J González Ferrer; M Arenas
Journal:  Clin Transl Oncol       Date:  2018-05-23       Impact factor: 3.405

2.  Radiotherapy-induced malfunctions of cardiac implantable electronic devices in cancer patients.

Authors:  Vincenzo L Malavasi; Giuseppina De Marco; Jacopo F Imberti; Filippo Placentino; Marco Vitolo; Ercole Mazzeo; Gianfranco Cicoria; Edoardo Casali; Vincenzo Turco; Frank Lohr; Giuseppe Boriani
Journal:  Intern Emerg Med       Date:  2019-12-02       Impact factor: 3.397

3.  A randomized in vitro evaluation of transient and permanent cardiac implantable electronic device malfunctions following direct exposure up to 10 Gy.

Authors:  Maria Daniela Falco; Domenico Genovesi; Luciana Caravatta; Clelia Di Carlo; Ekaterina Bliakharskaia; Marianna Appignani; Massimiliano Faustino; Nanda Furia; Enrico Di Girolamo
Journal:  Strahlenther Onkol       Date:  2020-06-19       Impact factor: 3.621

4.  Effect of X-ray dose rates higher than 8 Gy/min on the functioning of cardiac implantable electronic devices.

Authors:  Kazuhiko Nakamura; Takahiro Aoyama; Naoki Kaneda; Masashi Otsuji; Yoshitaka Minami; Ami Sakuragi; Masaru Nakamura
Journal:  J Radiat Res       Date:  2020-05-22       Impact factor: 2.724

5.  Radiotherapy in patients with cardiac implantable electronic devices: clinical and dosimetric aspects.

Authors:  Giulia Riva; Ombretta Alessandro; Ruggero Spoto; Annamaria Ferrari; Cristina Garibaldi; Federica Cattani; Rosa Luraschi; Elena Rondi; Nicola Colombo; Fulvio Lorenzo Francesco Giovenzana; Carlo Maria Cipolla; Mikolaj Winnicki; Martina Persiani; Fabiana Castelluccia; Massimo Sarra Fiore; Roberto Orecchia; Barbara Alicja Jereczek-Fossa
Journal:  Med Oncol       Date:  2018-04-17       Impact factor: 3.064

6.  Radiotherapy of patients with cardiac implantable electronic devices according to the DEGRO/DGK guideline-is the risk of relevant errors overestimated?

Authors:  Felix Steger; Matthias G Hautmann; Christoph Süß; Ute Hubauer; Ekrem Ücer; Lars Maier; Oliver Kölbl; Carsten Jungbauer
Journal:  Strahlenther Onkol       Date:  2019-08-09       Impact factor: 3.621

7.  A clinical example of extreme dose exposure for an implanted cardioverter-defibrillator : Beyond the DEGRO guidelines.

Authors:  Yoana Hristova; Janett Köhn; Stefanie Preuß; Claus Rödel; Panagiotis Balermpas
Journal:  Strahlenther Onkol       Date:  2017-05-31       Impact factor: 3.621

Review 8.  Management of radiation therapy patients with cardiac defibrillator or pacemaker.

Authors:  Francesca Salerno; Sara Gomellini; Cristina Caruso; Raffaele Barbara; Daniela Musio; Tamara Coppi; Mario Cardinale; Vincenzo Tombolini; Ugo de Paula
Journal:  Radiol Med       Date:  2015-12-26       Impact factor: 3.469

Review 9.  Accelerated Partial Breast Irradiation in Clinical Practice.

Authors:  Frederik Wenz; Felix Sedlmayer; Carsten Herskind; Grit Welzel; Elena Sperk; Christian Neumaier; Benjamin Gauter-Fleckenstein; Jayant S Vaidya; Marc Sütterlin
Journal:  Breast Care (Basel)       Date:  2015-07-15       Impact factor: 2.860

10.  PAIDEIA: pacemaker and implanted cardioverter defibrillator management in radiation therapy-a survey by the Young Group of the Italian Association of Radiotherapy and Clinical Oncology (AIRO).

Authors:  Anna Rita Alitto; Silvia Chiesa; Pierfrancesco Franco; Michele Fiore; Lorenza Marino; Paolo Borghetti; Isacco Desideri; Daniela Greto; Alba Fiorentino
Journal:  Radiol Med       Date:  2019-12-12       Impact factor: 3.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.